Stratec SE (XETRA: SBS.DE) Stock Competitors & Peer Comparison
See SBS.DE's competitors and their performance on the XETRA and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for SBS.DE and its XETRA peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SBS.DE | €24.25 | +0.83% | 294.8M | 34.37 | €0.71 | +2.47% |
| ABL.DE | €89.60 | +1.98% | 155B | 23.41 | €3.83 | +2.36% |
| 2M6.DE | €80.98 | +0.42% | 103.7B | 17.05 | €4.75 | +3.04% |
| SYK.DE | €240.30 | -1.86% | 91.8B | 25.47 | €9.40 | +1.25% |
| SHL.DE | €37.77 | -1.69% | 42.3B | 16.08 | €2.35 | +2.65% |
| PHI1.DE | €21.51 | -0.05% | 21B | 16.91 | €1.27 | +3.95% |
| DRW3.DE | €114.00 | -0.87% | 2.1B | 12.51 | €9.11 | +1.99% |
| DRW8.DE | €85.80 | -0.92% | 2.1B | 9.44 | €9.09 | +1.99% |
| GME.DE | €2.45 | +0.00% | 13.3M | 3.89 | €0.63 | +4.08% |
| E8X.DE | €0.14 | +1.45% | 1.5M | -1.08 | -€0.13 | N/A |
Stock Comparison
Abbott Laboratories (XETRA: ABL.DE)
SBS.DE vs ABL.DE Comparison September 2026
Stratec SE (XETRA: SBS.DE) plays a significant role within the Healthcare sector. Its performance on the XETRA reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBS.DE stands at 294.8M. In comparison, ABL.DE has a market cap of 155B. Regarding current trading prices, SBS.DE is priced at €24.25 on the XETRA, while ABL.DE trades at €89.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBS.DE currently has a P/E ratio of 34.37, whereas ABL.DE's P/E ratio is 23.41. In terms of profitability, SBS.DE's ROE is -0.00%, compared to ABL.DE's ROE of +0.11%. Regarding short-term risk, SBS.DE is more volatile compared to ABL.DE. This indicates higher risk in terms of short-term price fluctuations for SBS.DE.Check ABL.DE's competition here